Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Eclipta alba phytosomes improve bioavailability and therapeutic effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Inhibiting ODC can prevent UV-induced skin cancer.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.